Clinical Trials

VT3989 shows 32% response rate and 86% disease control in refractory mesothelioma. Learn about this first-in-class TEAD inhibitor's path to FDA approval and clinical trial access.

Mayo Clinic's #1-ranked mesothelioma program delivers multidisciplinary treatment with access to clinical trials across Rochester, Phoenix, and Jacksonville locations.

Compare EPP and P/D surgery for mesothelioma, understand survival rates, and learn about emerging surgical techniques. Expert guide to choosing the right procedure for your diagnosis.

Memorial Sloan Kettering Cancer Center offers pioneering mesothelioma surgery, immunotherapy, and clinical trials. Learn about MSK's treatment approach, specialists, and how to become a patient.

MD Anderson Cancer Center in Houston offers world-class mesothelioma treatment with pioneering surgical techniques and clinical trials. Learn what to expect and how to access care.

FDA-approved immunotherapy drugs Keytruda and Opdivo are transforming mesothelioma treatment. Learn how checkpoint inhibitors work, who qualifies, and what results patients are seeing in 2026.

56+ active mesothelioma clinical trials offer access to breakthrough treatments in 2026. Learn about immunotherapy, CAR T-cell therapy, and targeted treatments that are quadrupling survival rates.

These 6 specialized mesothelioma treatment centers offer access to expert surgeons, clinical trials, and survival rates 20-40% higher than general hospitals. Learn what makes each center unique.